Publications dans lesquelles il/elle collabore avec José Luis Vicario Moreno (30)

2024

  1. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

    Cytotherapy, Vol. 26, Núm. 1, pp. 25-35

2023

  1. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

2022

  1. Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy

    Immunology, Vol. 165, Núm. 2, pp. 234-249

2021

  1. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

    Trials, Vol. 22, Núm. 1

  2. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

    EClinicalMedicine, Vol. 39

2018

  1. Characterization of the novel HLA-A*80:04 allele identified in a Spanish volunteer donor

    HLA, Vol. 92, Núm. 4, pp. 245-246

2016

  1. Genomic full-length sequence of two new HLA-C alleles, HLA-C*04:239 and HLA-C*05:137

    HLA

  2. Genomic sequence of HLA-B*41:43, a new HLA-B allele generated by an intralocus recombination mechanism

    HLA, Vol. 87, Núm. 2, pp. 111-113

  3. The new HLA-A*24:321 shows one conservative amino acid replacement compared with HLA-A*24:02:01

    HLA, Vol. 87, Núm. 1, pp. 50-51

2015

  1. A new HLA-B allele, B*49:34, sequenced in a Spanish individual

    Tissue Antigens, Vol. 85, Núm. 4, pp. 293-294

2014

  1. Characterization of a novel HLA-DRB1 allele: DRB1*11:153

    Tissue Antigens, Vol. 83, Núm. 4, pp. 297-298

2012

  1. Sequencing of two novel HLA-A 29 alleles, A 29:39 and A 29:40

    Tissue Antigens, Vol. 80, Núm. 6, pp. 541-542

2002

  1. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients

    Cancer Research, Vol. 62, Núm. 17, pp. 5013-5018

  2. Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA-C null allele, Cw*0409 N

    Tissue Antigens, Vol. 59, Núm. 2, pp. 95-100

2001

  1. Identification by sequencing based typing and complete coding region analysis of three new HLA class 11 alleles: DRB3*0210, DRB3*0211 and DQB1*0310

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 354

  2. Lack of surface expression in two HLA class I alleles: A11 alternative spliced mRNA and CW*04011 null

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 229

  3. Sequencing based typing for HLA-C. Identification of three new alleles: Cw*0307, Cw*0502 and Cw*0504

    Tissue Antigens, Vol. 58, Núm. 1, pp. 34-37

2000

  1. HLA-Cw*1404: A new HLA-C allele with a hybrid 77Asn-80Asn NK motif

    Immunogenetics, Vol. 51, Núm. 7, pp. 610-612

  2. Identification by sequencing based typing and complete coding region analysis of three new HLA class II alleles: DRB3*0210, DRB3*0211 and DQB1*0310

    Tissue Antigens, Vol. 56, Núm. 4, pp. 380-384

  3. Intestinal αβ T cells of symptomatic celiac disease patients show oligoclonal TCRBV repertoire but polyclonal rearrangement patterns

    Human Immunology, Vol. 61, Núm. 3, pp. 247-254